Comparative proton nuclear magnetic resonance studies of amantadine complexes formed in aqueous solutions with three major cyclodextrins

Journal of Pharmaceutical Sciences

Volumn 103, Issue 1, 2014, Pages 274-282

  Lis Cieplak, Agnieszka ^a   Sitkowski, Jerzy ^b   Kolodziejski, Waclaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

amantadine; binding constants; complexation; cyclodextrins; diffusion; DOSY; inclusion compounds; NMR spectroscopy; ROESY

Indexed keywords

ALPHA CYCLODEXTRIN; AMANTADINE; BETA CYCLODEXTRIN; GAMMA CYCLODEXTRIN;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; COMPARATIVE STUDY; MOLECULAR INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY;

AMANTADINE; BINDING CONSTANTS; COMPLEXATION; CYCLODEXTRINS; DIFFUSION; DOSY; INCLUSION COMPOUNDS; NMR SPECTROSCOPY; ROESY;

AMANTADINE; CYCLODEXTRINS; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; SOLUTIONS; WATER;

EID: 84890526753     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23802     Document Type: Article

References (44)

1. Dodziuk H., 2006. Molecules with holes-Cyclodextrins. In Cyclodextrins and their complexes: Chemistry, analytical methods, applications;, Dodziuk H, Ed. Weinheim, Germany: Wiley-VCH, pp 1-30.
2. Uekama K, Hirayama F, Irie T,. 1998. Cyclodextrin drug carrier systems. Chem Rev 98: 2045-2076.
3. Loftsson T, Brewster ME,. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85: 1017-1025.
4. Loftsson T, Duchêne D,. 2007. Cyclodextrins and their pharmaceutical applications. Int J Pharm 329: 1-11.
5. Rajewski RA, Stella VJ,. 1996. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85: 1142-1169.
6. Brewster ME, Loftsson T,. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59: 645-666.
7. Lamoureux G, Artavia G,. 2010. Use of the adamantane structure in medicinal chemistry. Curr Med Chem 17: 2967-2978.
8. Liu J, Obando D, Liao V, Lifa T, Codd R,. 2011. The many faces of the adamantyl group in drug design. Eur J Med Chem 46: 1949-1963.
9. Spector R., 1988. Transport of amantadine and rimantadine through the blood-brain barrier. J Pharmacol Exp Ther 244 (2): 516-519.
10. Makarova NV, Boreko EI, Moiseev IK, Pavlova NI, Nikolaeva SN, Zemtsova MN, Vladyko GV,. 2002. Antiviral activity of adamantane-containing heterocycles. Pharm Chem J-USSR 36: 3-6.
11. Orzeszko A, Kamińska B, Orzeszko G, Starościak BJ,. 2000. Synthesis and antimicrobial activity of new adamantane derivatives II. Farmaco 55: 619-623.
12. Skolimowski J, Kochman A, Gebicka L, Metodiewa D,. 2003. Synthesis and antioxidant activity evaluation of novel antiparkinsonian agents, aminoadamantane derivatives of nitroxyl free radical. Bioorg Med Chem 1: 3529-3539.
13. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G,. 1997. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies. Neurosci Biobehav Rev 21: 455-468.
14. Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D,. 2006. Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev 2: CD001169.
15. Cady SD, Schmidt-Rohr K, Wang J, Soto CS, De Grado WF, Hong M,. 2010. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 463: 689-692.
16. 1H} NOE determinations and molecular mechanics calculations. J Mol Struct 248: 317-329.
17. 1H-NMR studies of the inclusion complexes between α-cyclodextrin and adamantane derivatives using both exchangeable hydroxy protons and non-exchangeable aliphatic protons. J Incl Phenom Macro 50: 173-181.
18. Tošner Z, Nikkhou Aski S, Kowalewski J,. 2006. Rotational dynamics of adamantanecarboxylic acid in complex with β-cyclodextrin. J Incl Phenom Macro 55: 59-70.
19. Rüdiger V, Eliseev A, Simova S, Schneider HJ, Blandamer MJ, Cullis PM, Meyer AJ,. 1996. Conformational, calorimetric and NMR spectroscopic studies on inclusion complexes of cyclodextrins with substituted phenyl and adamantane derivatives. J Chem Soc Perkin Trans 2: 2119-2123.
20. Carrazana J, Jover A, Meijide F, Soto VH, Vázquez Tato J,. 2005. Complexation of adamantyl compounds by β-cyclodextrin and monoaminoderivatives. J Phys Chem B 109: 9719-9726.
21. Gelb RI, Schwartz LM, Laufer DA,. 1984. Adamantan-1-ylamine and adamantan-1-ylamine hydrochloride complexes with cycloamyloses. J Chem Soc Perkin Trans 2: 15-21.
22. Vashi PR, Cukrowski I, Havel JS,. 2001. Stability constants of the inclusion complexes of β-cyclodextrin with various adamantane derivatives. A UV-Vis study. Afr J Chem 54: 84-101.
23. Gelb RI, Schwartz LM,. 1989. Complexation of adamantane-ammonium substrates by beta-cyclodextrin and its O-methylated derivatives. J Incl Phenom Mol Recognit Chem 7: 537-543.
24. Holzgrabe U, Wawer I, Diehl B,. 2008. NMR spectroscopy in pharmaceutical analysis. Oxford, United Kingdom: Elsevier.
25. Heller M, Kessler H,. 2001. NMR spectroscopy in drug design. Pure Appl Chem 73: 1429-1436.
26. Ejchart A, Koźmiński W,. 2006. NMR of cyclodextrins and their complexes. In Cyclodextrins and their complexes: Chemistry, analytical methods, applications;, Dodziuk H, Ed. Weinheim, Germany: Wiley-VCH, pp 231-254.
27. Ripmeester JA, Ratcliffe CI,. 2008. Solid-state NMR in host-guest chemistry. In Modern magnetic resonance part 5: Host-guest chemistry;, Webb GA, Ed. Dordrecht, The Netherlands: Springer, pp 147-154.
28. 1HNMR studies on the hydrogen-bonding network in mono-altro-β- cyclodextrin and its complex with adamantane-1-carboxylic acid. Carbohydr Res 340: 1539-1545.
29. Soto, Tellini VH, Jover A, Carrazana García J, Galantini L, Meijide F, Vázquez Tato J,. 2006. Thermodynamics of formation of host-guest supramolecular polymers. J Am Chem Soc 128: 5728-5734.
30. Loftsson T, Brewster ME, Másson M,. 2004. Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv 2: 261-275.
31. Loftsson T, Masson M,. 2001. Cyclodextrins in topical drug formulations: Theory and practice. Int J Pharm 225: 15-30.
32. Job P,. 1928. Formation and stability of inorganic complexes in solution. Ann Chim 9: 113-203.
33. Hwang TL, Shaka AJ,. 1993. Reliable two-dimensional rotating-frame cross-relaxation measurements in coupled spin systems. J Magn Reson B 102: 155-165.
34. Li ZZ, Guo QX, Ren T, Zhu XQ, Liu YC,. 1993. Can TMS and DSS be used as NMR references for cyclodextrin species in aqueous solution? J Inclus Phenom Mol 15: 37-42.
35. Pelta MD, Morris GA, Stchedroff MJ, Hammond SJ,. 2002. A one-shot sequence for high-resolution diffusion-ordered spectroscopy. Mag Res Chem 40: 147-152.
36. Nilsson M, Morris GA,. 2008. Speedy component resolution: An improved tool for processing diffusion-ordered spectroscopy data. Anal Chem 80: 3777-3782.
37. Nilsson M., 2009. The DOSYToolbox: A new tool for processing PFGNMR diffusion data. J Mag Reson 200: 296-302.
38. Rekharsky MV, Inoue Y,. 2006. Microcalorimetry. In Cyclodextrins and their complexes: Chemistry, analytical methods, applications;, Dodziuk H, Ed. Weinheim, Germany: Wiley-VCH, pp 199-230.
39. a) from solution NMR data. Tetrahedron 56: 6151-6170.
40. Cameron KS, Fielding L,. 2001. NMR diffusion spectroscopy as a measure of host-guest complex association constants and as a probe of complex size. J Org Chem 66: 6891-6895.
41. Bednarek E, Bocian W, Michalska K,. 2008. NMR and molecular modeling study, as complementary techniques to capillary electrophoresis method to elucidate the separation mechanism of linezolid enantiomers. J Chromatogr A 1193: 164-171.
42. Szejtli J,. 1998. Introduction and general overview of cyclodextrin chemistry. Chem Rev 98: 1743-1753.
43. Claridge TDW., 2009. Chapter 8. Correlations through space: The nuclear Overhauser effect. In Tetrahedron organic chemistry volume 27: High-resolution NMR 2nd ed. Oxford, United Kingdom: Elsevier, pp 247-302.
44. Schneider HJ, Hacket F, Rüdiger V, Ikeda H,. 1998. NMR studies of cyclodextrins and cyclodextrin complexes. Chem Rev 98: 1755-1785.